Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Bedzin

7 clinical trials in Bedzin, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Bedzin at a glance
7
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Bedzin

Open in trial search
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Clindamycin Phosphate
  • Sponsor:Adamed Pharma S.A.
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Methylprednisolone
  • Sponsor:Celltrion Inc.
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:F. Hoffmann-La Roche AG
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:F. Hoffmann-La Roche AG

Asthma

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.

Asthma

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dexpramipexole Dihydrochloride Monohydrate
  • Sponsor:Areteia Therapeutics Inc.

Other cities in Poland

The busiest research cities in the country

All 239 cities in Poland

Clinical research in Bedzin

What the registry says about research in the country

01 Neurology Research

Innovative clinical research focusing on Multiple Sclerosis, specifically examining new therapeutic approaches for patients with the relapsing-remitting form of the disease. These trials aim to evaluate treatment effectiveness and safety profiles of novel medications.

  • Relapsing-Remitting Multiple Sclerosis (RRMS)
  • Comparative Treatment Studies
  • Therapeutic Efficacy Assessment

The research emphasizes improving treatment options for MS patients through comprehensive clinical evaluation.

02 Respiratory Medicine

Groundbreaking research in severe eosinophilic asthma, investigating new therapeutic approaches to reduce severe asthma exacerbations. Long-term studies are being conducted to evaluate treatment effectiveness over extended periods.

  • Severe Asthma Management
  • Exacerbation Prevention
  • 52-Week Treatment Evaluation

These trials focus on developing targeted treatments for patients with severe asthmatic conditions.

03 Pulmonary Function Studies

Focused research on eosinophilic asthma examining pulmonary function improvements through innovative therapeutic approaches. The studies aim to enhance breathing capabilities and overall respiratory health.

  • Pulmonary Function Assessment
  • Respiratory Health Optimization
  • 24-Week Clinical Evaluation

This research targets specific improvements in lung function for asthma patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.